ZLAB

Zai Lab
ZLAB

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$2.91B
EV
$2.37B
Shares Outstanding
111.27M
Beta
0.85
Industry
Biotechnology

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
12
P/E 2025E
-
P/Revenue 2025E
5.23x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Zai Lab Limited

gainify
ZLAB

Zai Lab Limited

ZLAB

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses elect...

Sector

Healthcare

Industry

Biotechnology

CEO

Du, Ying

Employees

1,869

IPO Date

2017-09-20

Headquarters

Jinchuang Plaza, Building 1, Fourth Floor, 4560 Jinke Road, Pudong, Shanghai 201210, China

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.